Squawk on the Street podcast

Cramer's Morning Take: Microsoft & Viking Therapeutics 3/26/24

0:00
3:37
Rewind 15 seconds
Fast Forward 15 seconds

Jim and Jeff discuss the analyst price target increase for Microsoft. They also talk about the weight loss drug opportunity for Viking Therapeutics. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake  

CNBC Investing Club Disclaimer

More episodes from "Squawk on the Street"